Risk Factors for Perimegaprosthetic Infections After Tumor Resection

Orthopedics
|December 8, 2016
PubMed

Insights

Periprosthetic joint infections are a major risk after tumor resection megaprosthetic replacement. Factors influencing these infections are linked to the surgical procedure and hospitalization, requiring careful consideration by physicians.

Area of Science:

  • Orthopedics
  • Oncology
  • Infectious Diseases

Background:

  • Periprosthetic joint infection (PJI) is a significant complication after megaprosthetic replacement in tumor resection.
  • Managing PJI presents substantial challenges in orthopedic oncology.

Purpose of the Study:

  • To systematically review and identify risk factors associated with perimegaprosthetic joint infections following tumor resection megaprosthetic replacement.

Main Methods:

  • A systematic literature review was conducted, including English-language studies published up to July 2015.
  • Eight studies met the inclusion criteria for risk factor analysis.

Main Results:

  • Identified risk factors for perimegaprosthetic joint infections were predominantly associated with the surgical procedure.
  • Hospitalization-related factors also emerged as significant contributors to infection risk.

Conclusions:

  • Physicians should integrate these findings into patient discussions regarding limb salvage surgery outcomes.
  • Understanding these risk factors is crucial for reducing the incidence and burden of perimegaprosthetic joint infections.